CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg 2024; 72(S 03): e16-e29
DOI: 10.1055/a-2350-7374
Pediatric and Congenital Cardiology

German Registry for Cardiac Operations and Interventions in Congenital Heart Disease: Annual Report 2022

1   Department of Pediatric Cardiology, University Hospital Tuebingen, Tuebingen, Germany
,
Claudia Arenz
2   German Pediatric Heart Center, University of Bonn, Bonn, Germany
,
Ulrike M. M. Bauer
3   National Register for Congenital Heart Defects, Berlin, Germany
,
Alexander Horke
4   Division of Surgery for Congenital Heart Defects, Department of Cardiac Surgery, University of Hannover, Hannover, Germany
,
Gunter Kerst
5   Clinic for Pediatric Cardiology and Congenital Heart Disease, Stuttgart, Germany
,
Renate Meyer
6   BQS Institute for Quality and Patient Safety, Hamburg, Germany
,
Anja Tengler
7   Division of Pediatric Cardiology and Pediatric Intensive Care, Ludwig Maximilian University of Munich, Munich, Germany
,
8   Clinic for Cardiac Surgery and Pediatric Cardiac Surgery Heart Center Duisburg, Duisburg, Germany
› Author Affiliations
Funding The responsible bodies for the registry are the German Society for Thoracic and Cardiovascular Surgery (DGTHG) and the German Society for Pediatric Cardiology and Congenital Heart Defects (DGPK). The registry receives financial support from all participating institutions. From 2012 to 2016, the registry was funded by the German Heart Foundation (DHS).

Abstract

Background The German Registry for Cardiac Operations and Interventions in Patients with Congenital Heart Disease is a voluntary registry initiated by the German Society for Thoracic and Cardiovascular Surgery and the German Society for Pediatric Cardiology and Congenital Heart Defects. Since 2012, the registry collects data for the assessment of treatment and outcomes of surgical and interventional procedures in patients with congenital heart disease (CHD) of all age groups.

Methods This real-world, prospective all-comers registry collects clinical and procedural characteristics, adverse events (AEs), mortality, and medium-term outcomes (up to 90 days) of patients undergoing surgical and interventional. A unique pseudonymous personal identifier (PID) allows longitudinal data acquisition in case of further invasive treatment in any participating German heart center. Prior to evaluation, all data sets are monitored for data completeness and integrity. Evaluation includes risk stratification of interventional and surgical procedures and classification of AEs. Each year's data are summarized in annual reports containing detailed information on the entire cohort, all subgroups, and 15 index procedures. In addition, each participating center receives an institutional benchmark report for comparison with the national results. This paper presents a comprehensive summary of the annual report 2021.

Results In 2021, a total of 5,439 patients were included by 22 participating centers. In total, 3,721 surgical, 3,413 interventional, and 34 hybrid procedures were performed during 6,122 hospital stays. 2,220 cases (36.3%) could be allocated to the 15 index procedures. The mean unadjusted in-hospital mortality ranged from 0.4% among interventional and 2% among surgical cases up to 6.2 % in cases with multiple procedures. In-hospital mortality among index procedures accounted for 2.3% in total cavopulmonary connection, 20.3% in Norwood procedures, and 0.4% following interventional closure of patent ductus arteriosus. For the remaining seven surgical and five interventional index procedures, no in-hospital deaths were recorded. The 10-year longitudinal evaluation of 1,795 patients after tetralogy of Fallot repair revealed repeat interventional or surgical procedures in 21% of the patients. Over the same period, 31.1% of 2,037 patients, following initial treatment of native coarctation, required at least one additional hospital admission, 39.4% after initial interventional, and 21.3% after initial surgical therapy.

Conclusion The annual report 2021 of the German Registry for Cardiac Operations and Interventions in CHD shows continuously good results in accordance with previous data of the registry. Compared to international registries on CHD, it can be ascertained that in Germany invasive treatment of CHD is offered on a high medical level with excellent quality. The proven fact that patients with various malformations like tetralogy of Fallot and coarctation of the aorta require repeat procedures during follow-up confirms the urgent requirement for longitudinal assessment of all patients presenting with complex lesions.

Abbreviations

AE Adverse events


ASD Atrial septal defect


AVSD Atrioventricular septal defect


CHD Congenital heart disease


ECC Extracorporeal circulation


GA General anaesthesia


ICU Intensive care unit


PDA Patent ductus arteriosus


COA Native coarctation


ReCOA Re-Coarctation


PVR Pulmonary valve replacement


PPVI Percutaneous pulmonary valve replacement


TCPC Total cavopulmonary connection


TGA Transposition of the great arteries with intact ventricular septum


TOF Tetralogy of Fallot


VSD Ventricular septal defect




Publication History

Received: 05 June 2024

Accepted: 06 June 2024

Accepted Manuscript online:
24 June 2024

Article published online:
09 July 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 O'Brien SM, Clarke DR, Jacobs JP. et al. An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg 2009; 138 (05) 1139-1153
  • 2 Bergersen L, Gauvreau K, Marshall A. et al. Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv 2011; 4 (02) 188-194
  • 3 Bergersen L, Gauvreau K, Foerster SR. et al. Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv 2011; 4 (09) 1037-1046
  • 4 Jayaram N, Spertus JA, Kennedy KF. et al. Modeling major adverse outcomes of pediatric and adult patients with congenital heart disease undergoing cardiac catheterization: observations from the NCDR IMPACT Registry (National Cardiovascular Data Registry Improving Pediatric and Adult Congenital Treatment). Circulation 2017; 136 (21) 2009-2019
  • 5 Overman DM, Jacobs ML, O'Brien Jr JE. et al. Ten years of data verification: The Society of Thoracic Surgeons Congenital Heart Surgery Database Audits. World J Pediatr Congenit Heart Surg 2019; 10 (04) 454-463
  • 6 Herbst C, Tobota Z, Urganci E. et al. Ten years of data verification: the European Congenital Heart Surgeons Association Congenital Database Audits. World J Pediatr Congenit Heart Surg 2022; 13 (04) 466-474
  • 7 Quinn BP, Yeh M, Gauvreau K. et al. Procedural risk in congenital cardiac catheterization (PREDIC3T). J Am Heart Assoc 2022; 11 (01) e022832
  • 8 McCrossan BA, Karayiannis S, Shields M. et al. Incidence, predictors, and outcomes of cardiac perforation during pediatric cardiac catheterization: a retrospective observational study from the Congenital Cardiac Interventional Study Consortium (CCISC). Pediatr Cardiol 2023; 44 (04) 867-872
  • 9 Jacobs JP, Krasemann T, Herbst C. et al. Combining congenital heart surgical and interventional cardiology outcome data in a single database: the development of a patient-centered collaboration of the European Congenital Heart Surgeons Association (ECHSA) and the Association for European Paediatric and Congenital Cardiology (AEPC). Cardiol Young 2023; 33 (07) 1043-1059
  • 10 Beckmann A, Dittrich S, Arenz C. et al; German Quality Assurance / Competence Network for Congenital Heart Defects Investigators. German Registry for cardiac operations and interventions in patients with congenital heart disease: report 2020-comprehensive data from 6 years of experience. Thorac Cardiovasc Surg 2021; 69 (S03): e21-e31
  • 11 Dittrich S, Arenz C, Krogmann O. et al. German Registry for cardiac operations and interventions in patients with congenital heart disease: report 2021 and 9 years' longitudinal observations on Fallot and coarctation patients. Thorac Cardiovasc Surg 2022; 70 (S 03): e21-e33
  • 12 Hoffmann W, Latza U, Baumeister SE. et al. Guidelines and recommendations for ensuring Good Epidemiological Practice (GEP): a guideline developed by the German Society for Epidemiology. Eur J Epidemiol 2019; 34 (03) 301-317
  • 13 Guideline for Good Clinical Practice. Accessed June 21, 2024 at: https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice
  • 14 World Medical Association. WMA Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects. Accessed January 11, 2021 at: https://www.wma.net/policiespost/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
  • 15 Franklin RCG, Béland MJ, Colan SD. et al. Nomenclature for congenital and paediatric cardiac disease: the International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Iteration of the International Classification of Diseases (ICD-11). Cardiol Young 2017; 27 (10) 1872-1938
  • 16 Jacobs JP, Franklin RCG, Béland MJ. et al. Nomenclature for pediatric and congenital cardiac care: unification of clinical and administrative nomenclature. — The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11). Cardiol Young 2021; 31 (07) 1057-1188
  • 17 Jacobs ML, O'Brien SM, Jacobs JP. et al. An empirically based tool for analyzing morbidity associated with operations for congenital heart disease. J Thorac Cardiovasc Surg 2013; 145 (04) 1046-1057.e1
  • 18 Deutscher Herzbericht. 2022 . Accessed May 14, 2024 at: https://epaper.herzstiftung.de/#0
  • 19 Beckmann A, Meyer R, Lewandowski J, Markewitz A, Blaßfeld D, Böning A. German Heart Surgery Report 2021: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2022; 70 (05) 362-376
  • 20 Bertsimas D, Zhuo D, Levine J. et al. Benchmarking in congenital heart surgery using machine learning-derived optimal classification trees. World J Pediatr Congenit Heart Surg 2022; 13 (01) 23-35
  • 21 Pasquali SK, Shahian DM, O'Brien SM. et al. Development of a congenital heart surgery composite quality metric: part 1-conceptual framework. Ann Thorac Surg 2019; 107 (02) 583-589
  • 22 Dorobantu DM, Mahani AS, Sharabiani MTA. et al. Primary repair versus surgical and transcatheter palliation in infants with tetralogy of Fallot. Heart 2018; 104 (22) 1864-1870
  • 23 Ravaglioli A, Ait-Ali L, Federici D. et al. The impact of native Fallot anatomy on future therapeutic requirements and outcomes at follow-up. Cardiovasc Ultrasound 2021; 19 (01) 23
  • 24 Pasquali SK, Thibault D, O'Brien SM. et al. National variation in congenital heart surgery outcomes. Circulation 2020; 142 (14) 1351-1360
  • 25 Jacobs ML, Jacobs JP, Thibault D. et al. Updating an empirically based tool for analyzing congenital heart surgery mortality. World J Pediatr Congenit Heart Surg 2021; 12 (02) 246-281
  • 26 Sarris GE, Zhuo D, Mingardi L. et al. Congenital heart surgery machine learning-derived in-depth benchmarking tool. Ann Thorac Surg 2023; (e-pub ahead of print)
  • 27 Foth R, Quentin T, Michel-Behnke I. et al. Immunohistochemical characterization of neotissues and tissue reactions to septal defect-occlusion devices. Circ Cardiovasc Interv 2009; 2 (02) 90-96
  • 28 Foth R, Shomroni O, Sigler M. et al. Screening for potential targets to reduce stenosis in bioprosthetic heart valves. Sci Rep 2021; 11 (01) 2464